232 related articles for article (PubMed ID: 3517506)
21. Effects of diltiazem cardioplegia on global function, segmental contractility, and the area of necrosis after acute coronary artery occlusion and surgical reperfusion.
Melendez FJ; Gharagozloo F; Sun SC; Benfell K; Austin RE; Shemin RJ; Cohn LH
J Thorac Cardiovasc Surg; 1988 Apr; 95(4):613-7. PubMed ID: 3352294
[TBL] [Abstract][Full Text] [Related]
22. Limitations of blood conservation.
Weisel RD; Charlesworth DC; Mickleborough LL; Fremes SE; Ivanov J; Mickle DA; Teasdale SJ; Glynn MF; Scully HE; Goldman BS
J Thorac Cardiovasc Surg; 1984 Jul; 88(1):26-38. PubMed ID: 6376959
[TBL] [Abstract][Full Text] [Related]
23. [Evaluation of the effectiveness and safety in the use of cold-diltiazem-potassium cardioplegia in coronary artery bypass surgery: a first clinical trial].
Kitamura S; Nishii T; Kawachi K; Koh Y; Morita R; Kim K; Oyama C
Nihon Geka Gakkai Zasshi; 1985 Sep; 86(9):1199-202. PubMed ID: 3911052
[TBL] [Abstract][Full Text] [Related]
24. Myocardial metabolism is better preserved after blood cardioplegia in infants.
Amark K; Berggren H; Björk K; Ekroth A; Ekroth R; Nilsson K; Sunnegårdh J
Ann Thorac Surg; 2006 Jul; 82(1):172-8. PubMed ID: 16798209
[TBL] [Abstract][Full Text] [Related]
25. Optimal postoperative volume loading.
Weisel RD; Burns RJ; Baird RJ; Hilton JD; Ivanov J; Mickle DA; Teoh KH; Christakis GT; Evans PJ; Scully HE; Goldman BS; McLaughlin PR
J Thorac Cardiovasc Surg; 1983 Apr; 85(4):552-63. PubMed ID: 6601212
[TBL] [Abstract][Full Text] [Related]
26. Protein kinase C isoform-dependent myocardial protection by ischemic preconditioning and potassium cardioplegia.
Lu K; Otani H; Yamamura T; Nakao Y; Hattori R; Ninomiya H; Osako M; Imamura H
J Thorac Cardiovasc Surg; 2001 Jan; 121(1):137-48. PubMed ID: 11135170
[TBL] [Abstract][Full Text] [Related]
27. Comparison of the effect of blood cardioplegia to crystalloid cardioplegia on myocardial contractility in man.
Shapira N; Kirsh M; Jochim K; Behrendt DM
J Thorac Cardiovasc Surg; 1980 Nov; 80(5):647-55. PubMed ID: 6968855
[TBL] [Abstract][Full Text] [Related]
28. Adenosine instead of supranormal potassium in cardioplegic solution improves cardioprotection.
Jakobsen Ø; Muller S; Aarsaether E; Steensrud T; Sørlie DG
Eur J Cardiothorac Surg; 2007 Sep; 32(3):493-500. PubMed ID: 17613242
[TBL] [Abstract][Full Text] [Related]
29. Continuous addition of adenosine with a micropump system improves warm whole blood cardioplegia.
Agnihotri AK; Recanati MA; White JK; Titus J; Fischer JI; Schon J; Torchiana DF
Heart Surg Forum; 2003; 6(4):264-72. PubMed ID: 12928212
[TBL] [Abstract][Full Text] [Related]
30. Improved myocardial protection with blood and crystalloid cardioplegia.
Weisel RD; Fremes SE; Baird RJ; Ivanov J; Madonik MM; Mickle DA
J Vasc Surg; 1984 Sep; 1(5):656-9. PubMed ID: 6389911
[TBL] [Abstract][Full Text] [Related]
31. Influence of diltiazem on cardiac function at organ and molecular level during hypothermic cardiac arrest.
Prasad K; Bharadwa B
Can J Cardiol; 1987 Oct; 3(7):351-6. PubMed ID: 2962705
[TBL] [Abstract][Full Text] [Related]
32. Cardiac metabolism and performance following cold potassium cardioplegia.
Weisel RD; Lipton IH; Lyall RN; Baird RJ
Circulation; 1978 Sep; 58(3 Pt 2):I217-26. PubMed ID: 14740705
[TBL] [Abstract][Full Text] [Related]
33. Elective cardiac arrest with a hyperpolarizing adenosine triphosphate-sensitive potassium channel opener. A novel form of myocardial protection?
Cohen NM; Wise RM; Wechsler AS; Damiano RJ
J Thorac Cardiovasc Surg; 1993 Aug; 106(2):317-28. PubMed ID: 7848379
[TBL] [Abstract][Full Text] [Related]
34. An asanguineous reperfusion solution. An effective adjunct to cardioplegic protection in high-risk valve operations.
Menasche P; Dunica S; Kural S; Touchot B; Chollet A; Steg G; Levard G; Lorente P; Piwnica A
J Thorac Cardiovasc Surg; 1984 Aug; 88(2):278-86. PubMed ID: 6748722
[TBL] [Abstract][Full Text] [Related]
35. A comparison of 250 and 500 mL of terminal warm blood cardioplegia after global myocardial ischemia: a prospective randomized study.
Akowuah EF; Riaz I; Shrivastava V; Onyeaka P; Cooper G
J Card Surg; 2005; 20(2):107-11. PubMed ID: 15725132
[TBL] [Abstract][Full Text] [Related]
36. Is blood superior to crystalloid cardioplegia? A meta-analysis of randomized clinical trials.
Guru V; Omura J; Alghamdi AA; Weisel R; Fremes SE
Circulation; 2006 Jul; 114(1 Suppl):I331-8. PubMed ID: 16820596
[TBL] [Abstract][Full Text] [Related]
37. Diazoxide protects myocardial mitochondria, metabolism, and function during cardiac surgery: a double-blind randomized feasibility study of diazoxide-supplemented cardioplegia.
Deja MA; Malinowski M; Gołba KS; Kajor M; Lebda-Wyborny T; Hudziak D; Domaradzki W; Szurlej D; Bończyk A; Biernat J; Woś S
J Thorac Cardiovasc Surg; 2009 Apr; 137(4):997-1004, 1004e1-2. PubMed ID: 19327530
[TBL] [Abstract][Full Text] [Related]
38. The effect of leukocyte-depleted blood cardioplegia in patients with severe left ventricular dysfunction: a randomized, double-blind study.
Roth M; Kraus B; Scheffold T; Reuthebuch O; Klövekorn WP; Bauer EP
J Thorac Cardiovasc Surg; 2000 Oct; 120(4):642-50. PubMed ID: 11003743
[TBL] [Abstract][Full Text] [Related]
39. Inadequate myocardial protection with cold cardioplegic arrest during repair of tetralogy of Fallot.
del Nido PJ; Mickle DA; Wilson GJ; Benson LN; Weisel RD; Coles JG; Trusler GA; Williams WG
J Thorac Cardiovasc Surg; 1988 Feb; 95(2):223-9. PubMed ID: 3257536
[TBL] [Abstract][Full Text] [Related]
40. [A clinical study of diltiazem administration using cold glucose-insulin-potassium cardioplegic solution--comparison between diltiazem cardioplegia and diltiazem pretreatment].
Koike R; Shiguma S; Suma H; Kondo K; Oku T; Kimura H; Satoh H; Sawada Y; Morita M; Ozeki M
Rinsho Kyobu Geka; 1989 Apr; 9(2):162-8. PubMed ID: 9301913
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
